U.S. Pen Needles Market Crosses $888M in 2024 : Ken Research Tracks Rise to $1.57B by 2030
U.S. Pen Needles Market Reaches $888M in 2024, Poised for $1.57B by 2030 | Ken Research Executive Summary The U.S. Pen Needles Market reached USD 888 million in 2024 , driven by a diabetic population of 37.3 million Americans and accelerating adoption of ultra-fine insulin delivery technology, positioning the sector for a 10.0% CAGR toward USD 1.57 billion by 2030 . The core tension shaping this market is structural: rising chronic disease burden collides with persistent affordability gaps, where 20% of diabetic patients struggle with pen needle costs of $25 to $50 per pack, forcing manufacturers to balance innovation with access. Ken Research finds that safety pen needles and ultra-fine 4mm/32G gauge products are capturing dominant share as self-administration overtakes clinic-based delivery, fundamentally reshaping the competitive landscape through 2030 . Explore the Full Report: U.S. Pen Needles Market Report | Ken Research delivers data-driven intelligence on med...